Home
Services Chevron
QC and R&D Services Technology and Compliance
About us Chevron
About company Quality Policy Statement
FAQ
Blog
info@labsense.hr Request pricing
Logo
Home

Services

QC and R&D Services Technology and Compliance

About us

About company Quality Policy Statement
FAQ
Blog

October 9th, 2024

1 min to read

Staying Ahead in Biopharmaceuticals

At LabSense, we're committed to staying at the forefront of scientific advancements in the pharmaceutical industry. That's why we recently participated in BIOCentre – Incubation centre for biosciences's "Characterization of Biological Drugs" event, held on May 21st, 2024.

The event covered a wide range of topics, delving into the process of creating and characterizing protein-based drugs, all the way to cell therapies. We gained valuable insights into protein construction, production, and purification, the importance of glycosylation, formulation strategies, regulatory considerations, advanced characterization techniques, solutions for oligonucleotide therapeutics, and cellular therapies.

By attending events like this, our team stays current on the latest trends and technologies, allowing us to better serve our clients and contribute to the progress of the pharmaceutical industry.

Recent posts

June 4th, 2025

A new formulation platform for poorly soluble APIs with potential application for dry eye – DEAP (Dry Eye API Platform)

June 4th, 2025

Benzene Testing in Benzoyl Peroxide (BPO) Products

November 24th, 2024

Innovation Vouchers for SMEs

Logo

Transform your lab with custom-designed solutions and expert consulting

/assets/fond1-white.svg


Designed and developed by Amelo Design

Sitemap

Home QC and R&D Services Technology and Compliance About company FAQ Blog

Contact

OIB: 29765016403

Borongajska cesta 83H, 10000 Zagreb

info@labsense.hr
Cookie Policy Privacy Statement Quality Policy Statement Terms of Use

Contact us

Thank you! Your message has been sent.
Cookie Consent

We use cookies to enhance your site experience. Choose your preferences below.